SERPINE3 Activators
SERPINE3, characterized by its predicted serine-type endopeptidase inhibitor activity, emerges as a pivotal player in the intricate web of cellular regulation. This multifunctional gene is forecasted to contribute significantly to the negative regulation of endopeptidase activity, operating predominantly within the extracellular space. The primary function of SERPINE3 lies in its ability to modulate serine-type endopeptidases, enzymes critical for various cellular processes. By inhibiting the activity of these endopeptidases, SERPINE3 plays a crucial role in fine-tuning the balance of proteolytic activities, thereby maintaining cellular homeostasis. Activation mechanisms of SERPINE3 involve a complex interplay of biochemical pathways and cellular processes. While the direct activators may not be explicitly identified, the gene's predicted function offers insights into potential indirect activation strategies. The intricate web of interactions encompasses extracellular proteases, fibrinolysis, coagulation, and metalloproteinases. These pathways represent the diverse cellular contexts where SERPINE3 is involved, influencing the negative regulation of endopeptidase activity. The up-regulation of SERPINE3 is intricately linked to the modulation of these pathways, suggesting a dynamic and context-dependent regulatory network.
Understanding the potential activators underscores the sophisticated nature of SERPINE3's activation mechanisms. The gene's involvement in these diverse pathways indicates its adaptability and responsiveness to various cellular cues. The activation of SERPINE3 is not a linear process but rather a network of interconnected events, highlighting the complexity of gene regulation in cellular contexts. Further research into the specific nuances of these activation mechanisms promises to unravel additional layers of complexity, providing valuable insights into the fine-tuned orchestration of cellular responses mediated by SERPINE3. In summary, SERPINE3's predicted function and activation mechanisms showcase its pivotal role in cellular regulation, offering a glimpse into the intricate dance of molecular interactions that contribute to maintaining the delicate equilibrium of cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Camostat mesylate | 59721-29-8 | sc-203867 sc-203867A sc-203867B sc-203867C sc-203867D sc-203867E | 10 mg 50 mg 500 mg 1 g 10 g 100 g | $43.00 $183.00 $312.00 $624.00 $2081.00 $4474.00 | 5 | |
Camostat inhibits serine proteases, potentially leading to the up-regulation of SERPINE3. It specifically targets TMPRSS2, an extracellular protease, modulating its activity and influencing the negative regulation of endopeptidase activity. The inhibition of TMPRSS2 could result in reduced cleavage and increased availability of SERPINE3, promoting its activity in regulating serine-type endopeptidases. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $82.00 $306.00 | 4 | |
Nafamostat is a serine protease inhibitor that may indirectly activate SERPINE3. By inhibiting various serine proteases in the extracellular space, it could disrupt the negative regulation of endopeptidase activity, potentially enhancing the function of SERPINE3. This interference with protease activity may trigger a cascade of events leading to the up-regulation of SERPINE3 and its subsequent inhibition of serine-type endopeptidases. | ||||||
Tranexamic acid | 1197-18-8 | sc-204921 sc-204921A | 5 g 10 g | $29.00 $50.00 | 10 | |
Tranexamic acid, known for its antifibrinolytic properties, may indirectly activate SERPINE3. By modulating the fibrinolysis pathway, it can impact the negative regulation of endopeptidase activity. The stabilization of fibrin clots through tranexamic acid might trigger a cellular response, leading to the up-regulation of SERPINE3, promoting its role in inhibiting serine-type endopeptidases. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
Aprotinin, a serine protease inhibitor, could potentially up-regulate SERPINE3. By inhibiting serine proteases in the extracellular space, it may disrupt the negative regulation of endopeptidase activity. This interference with protease activity might activate a cellular response, promoting the expression and function of SERPINE3 in inhibiting serine-type endopeptidases. | ||||||
Batimastat | 130370-60-4 | sc-203833 sc-203833A | 1 mg 10 mg | $179.00 $377.00 | 24 | |
Batimastat, a matrix metalloproteinase inhibitor, might indirectly activate SERPINE3. By affecting extracellular matrix remodeling, it could influence the negative regulation of endopeptidase activity. The inhibition of metalloproteinases may trigger cellular responses, potentially leading to the up-regulation of SERPINE3 and enhancing its role in inhibiting serine-type endopeptidases. | ||||||
Dabigatran | 211914-51-1 | sc-481166 | 5 mg | $205.00 | 1 | |
Dabigatran, a direct thrombin inhibitor, may indirectly activate SERPINE3. By modulating the coagulation pathway and inhibiting thrombin, it could impact the negative regulation of endopeptidase activity. The inhibition of thrombin may trigger cellular responses, potentially leading to the up-regulation of SERPINE3 and enhancing its role in inhibiting serine-type endopeptidases. | ||||||